Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks
- PMID: 38844190
- DOI: 10.1016/j.meegid.2024.105613
Illuminating the pathogenic role of SARS-CoV-2: Insights into competing endogenous RNAs (ceRNAs) regulatory networks
Abstract
The appearance of SARS-CoV-2 in 2019 triggered a significant economic and health crisis worldwide, with heterogeneous molecular mechanisms that contribute to its development are not yet fully understood. Although substantial progress has been made in elucidating the mechanisms behind SARS-CoV-2 infection and therapy, it continues to rank among the top three global causes of mortality due to infectious illnesses. Non-coding RNAs (ncRNAs), being integral components across nearly all biological processes, demonstrate effective importance in viral pathogenesis. Regarding viral infections, ncRNAs have demonstrated their ability to modulate host reactions, viral replication, and host-pathogen interactions. However, the complex interactions of different types of ncRNAs in the progression of COVID-19 remains understudied. In recent years, a novel mechanism of post-transcriptional gene regulation known as "competing endogenous RNA (ceRNA)" has been proposed. Long non-coding RNAs (lncRNAs), circular RNAs (circRNAs), and viral ncRNAs function as ceRNAs, influencing the expression of associated genes by sequestering shared microRNAs. Recent research on SARS-CoV-2 has revealed that disruptions in specific ceRNA regulatory networks (ceRNETs) contribute to the abnormal expression of key infection-related genes and the establishment of distinctive infection characteristics. These findings present new opportunities to delve deeper into the underlying mechanisms of SARS-CoV-2 pathogenesis, offering potential biomarkers and therapeutic targets. This progress paves the way for a more comprehensive understanding of ceRNETs, shedding light on the intricate mechanisms involved. Further exploration of these mechanisms holds promise for enhancing our ability to prevent viral infections and develop effective antiviral treatments.
Keywords: COVID-19; Viral RNA; ceRNA; circRNA; lncRNAs; mRNA; ncRNA.
Copyright © 2023. Published by Elsevier B.V.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Similar articles
-
Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19).Gene. 2020 Dec 15;762:145057. doi: 10.1016/j.gene.2020.145057. Epub 2020 Aug 15. Gene. 2020. PMID: 32805314 Free PMC article.
-
Identification of dysregulated competing endogenous RNA networks in glioblastoma: A way toward improved therapeutic opportunities.Life Sci. 2021 Jul 15;277:119488. doi: 10.1016/j.lfs.2021.119488. Epub 2021 Apr 19. Life Sci. 2021. PMID: 33862117 Review.
-
Non-coding RNAs identification and regulatory networks in pathogen-host interaction in the microsporidia congenital infection.BMC Genomics. 2023 Jul 26;24(1):420. doi: 10.1186/s12864-023-09490-3. BMC Genomics. 2023. PMID: 37495972 Free PMC article.
-
The interplay between lncRNAs, RNA-binding proteins and viral genome during SARS-CoV-2 infection reveals strong connections with regulatory events involved in RNA metabolism and immune response.Theranostics. 2022 May 9;12(8):3946-3962. doi: 10.7150/thno.73268. eCollection 2022. Theranostics. 2022. PMID: 35664076 Free PMC article.
-
Competitive endogenous RNA networks: Decoding the role of long non-coding RNAs and circular RNAs in colorectal cancer chemoresistance.J Cell Mol Med. 2024 Apr;28(7):e18197. doi: 10.1111/jcmm.18197. J Cell Mol Med. 2024. PMID: 38506091 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous